Cite
HARVARD Citation
Sullivan, I. et al. (n.d.). Osimertinib in the treatment of patients with epidermal growth factor receptor T790M mutation-positive metastatic non-small cell lung cancer: clinical trial evidence and experience. Therapeutic advances in respiratory disease. pp. 549-565. [Online].